Proton-pump inhibitor
Proton-pump inhibitors (PPIs) are a class of medications that cause a profound and prolonged reduction of stomach acid production. They do so by irreversibly inhibiting the stomach's H+/K+ ATPase proton pump. They are the most potent inhibitors of acid secretion available. Proton-pump inhibitors have largely superseded the H2-receptor antagonists, a group of medications with similar effects but a different mode of action.
Introduction
Proton-pump inhibitors (PPIs) are a class of drugs designed to dramatically decrease the production of gastric acid in the stomach. They accomplish this by irreversibly inhibiting the functionality of the stomach's H+/K+ ATPase (proton pump), an enzyme responsible for acid secretion. PPIs are considered the most effective inhibitors of gastric acid secretion currently available, and have largely replaced H2-receptor antagonists, which also inhibit acid secretion, but by a different mechanism.
Mechanism of Action of Proton-pump Inhibitors
PPIs function by selectively and irreversibly binding to the H+/K+ ATPase enzyme on gastric parietal cells. This enzyme is responsible for the final step in the production of gastric acid, namely the exchange of potassium ions (K+) for hydronium ions (H3O+) in the stomach.
By inhibiting the activity of this enzyme, PPIs effectively stop the secretion of gastric acid into the stomach. This action is dose-dependent and affects both basal and stimulated acid secretion, making PPIs the most potent inhibitors of acid secretion available.
Clinical Uses of Proton-pump Inhibitors
Proton-pump inhibitors have various clinical applications primarily related to conditions caused by excessive gastric acid secretion. These include:
- Gastroesophageal reflux disease (GERD): This is the most common use of PPIs, providing relief from the heartburn symptoms of GERD and allowing the esophagus to heal from any acid damage.
- Peptic ulcer disease (PUD): PPIs aid in the healing of gastric and duodenal ulcers and are also used in combination with antibiotics for eradication of Helicobacter pylori, a bacterium often associated with PUD.
- Zollinger-Ellison syndrome: This is a rare disorder characterized by severe peptic ulcers due to overproduction of gastric acid. PPIs are used to control acid hypersecretion.
- Prevention of Nonsteroidal anti-inflammatory drug (NSAID)-induced ulcers: Long-term use of NSAIDs can lead to peptic ulcers. PPIs are often co-prescribed with NSAIDs to prevent this.
Side Effects and Precautions
Although PPIs are generally well-tolerated, they are associated with several side effects and risks, including an increased susceptibility to gastrointestinal infections (due to the lack of protective gastric acid), vitamin B12 deficiency, and potential kidney disease with long-term use. Some studies have also suggested possible links to dementia and bone fractures, though these associations require further investigation.
Conclusion
Proton-pump inhibitors have revolutionized the management of acid-related disorders. Their potent acid-suppressive effects, combined with their safety profile, have made them an essential tool in the therapeutic arsenal against gastric acid-related conditions.
This article is a medical stub. You can help WikiMD by expanding it! | |
---|---|
Major chemical drug groups | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Drugs for peptic ulcer and GERD/GORD (A02B) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
References
- Sachs, G., Shin, J. M., & Howden, C. W. (2006). Review article: the clinical pharmacology of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 23, 2–8.
- Forgacs, I., & Loganayagam, A. (2008). Overprescribing proton pump inhibitors. BMJ, 336(7634), 2-3.
- Strand, D. S., Kim, D., & Peura, D. A. (2017). 25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut and liver.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD